Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL14736, Pliva, Croatia) Heals Ileoileal Anastomosis in the Rat (CROSBI ID 323638)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vuksic, Tihomir ; Zoricic, Ivan ; Brcic, Luka ; Sever, Marko ; Klicek, Robert ; Radic, Bozo ; Cesarec, Vedran ; Berkopic, Lidija ; Keller, Neike ; Blagaic, Alenka Boban et al. Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL14736, Pliva, Croatia) Heals Ileoileal Anastomosis in the Rat // Surgery today, 37 (2007), 9; 768-777. doi: 10.1007/s00595-006-3498-9

Podaci o odgovornosti

Vuksic, Tihomir ; Zoricic, Ivan ; Brcic, Luka ; Sever, Marko ; Klicek, Robert ; Radic, Bozo ; Cesarec, Vedran ; Berkopic, Lidija ; Keller, Neike ; Blagaic, Alenka Boban ; Kokic, Neven ; Jelic, Ivan ; Geber, Juraj ; Anic, Tomislav ; Seiwerth, Sven ; Sikiric, Predrag

engleski

Stable Gastric Pentadecapeptide BPC 157 in Trials for Inflammatory Bowel Disease (PL-10, PLD-116, PL14736, Pliva, Croatia) Heals Ileoileal Anastomosis in the Rat

Purpose: Gastric pentadecapeptide BPC 157 (BPC 157), which has been shown to be safe in clinical trials for inflammatory bowel disease (PL-10, PLD- 116, PL14736, Pliva, Croatia), may be able to cure intestinal anastomosis dehiscence. This antiulcer peptide shows no toxicity, is limit test negative, and a lethal dose is not achieved. It is stable in human gastric juice. In comparison with other standard treatments it is more effective for ulcers and various wounds, and can be used without a carrier needed for other peptides, both locally and systemically (i.e., perorally, parenterally). We studied the effectiveness of BPC 157 for ileoileal anastomosis healing in rats. Methods: We assessed ileoileal anastomosis dehiscence macroscopically, histologically, and biomechanically (volume [ml] infused through a syringe-perfusion pump system (1 ml/10 s), and pressure [mmHg] to leak induction [catheter connected to a chamber and a monitor, at 10 cm proximal to anastomosis]), at 1, 2, 3, 4, 5, 6, 7, and 14 days. BPC 157 (10 microg, 10 ng, 10 pg/kg i.p. (or saline [5 ml/kg]) was first administered after surgery, while it was last given 24 h before either assessment or sacrifice. Results: Throughout the experiment, both higher doses of BPC 157 were shown to improve all parameters of anastomotic wound healing. The formation of adhesions remained slight, the blood vessels were filled with blood, and a mild intestinal passage obstruction was only temporarily observed. Anastomosis without leakage induces markedly higher volume and pressure values, with a continuous increase toward healthy values. From day 1, edema was markedly attenuated and the number of granulocytes decreased, while from days 4 or 5 necrosis decreased and granulation tissue, reticulin, and collagen formation substantially increased, thus resulting in increased epithelization. Conclusion: This study showed BPC 157 to have a beneficial effect on ileoileal anastomosis healing in the rat.

Pentadecapeptide BPC 157, Ileoileal anastomosis healing, Rat

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

37 (9)

2007.

768-777

objavljeno

0941-1291

10.1007/s00595-006-3498-9

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje), Farmacija, Temeljne medicinske znanosti

Poveznice
Indeksiranost